![The latest ASCO podcast on the rapid guideline update on endocrine and targeted therapy for HR+, HER2+ metastatic breast cancer – Dana-Farber’s Breast Oncology Center](https://oncodaily.com/pub/uploads/2024/03/ASCO.jpg)
Mar 26, 2024, 04:50
The latest ASCO podcast on the rapid guideline update on endocrine and targeted therapy for HR+, HER2+ metastatic breast cancer – Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X/Twitter:
“Listen to the latest ASCO podcast where Dr. Angela DeMichele, Dr. Lynn Henry, and Dr. Harold Burstein discuss the rapid guideline update on endocrine and targeted therapy for HR+, HER2+ metastatic breast cancer.
Listen here.”
Source: Dana-Farber’s Breast Oncology Center /X